Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection.
about
Selective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispeciesRestrictions to cross-species transmission of lentiviral infection gleaned from studies of FIVFine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.Env-expressing autologous T lymphocytes induce neutralizing antibody and afford marked protection against feline immunodeficiency virusThe neuropathogenesis of feline immunodeficiency virus infection: barriers to overcomeIdentification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.Feline immunodeficiency virus in South America.Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection.A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction.Genetically divergent strains of feline immunodeficiency virus from the domestic cat (Felis catus) and the African lion (Panthera leo) share usage of CD134 and CXCR4 as entry receptors.The molecular biology of feline immunodeficiency virus (FIV).Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibodyEmergence of CD134 cysteine-rich domain 2 (CRD2)-independent strains of feline immunodeficiency virus (FIV) is associated with disease progression in naturally infected cats.Applications of the FIV Model to Study HIV Pathogenesis.
P2860
Q27318192-74155AAE-F8E5-40EB-8207-94201C08582DQ33515462-3F687AF1-4209-4992-BB6F-2EB16A8BF31FQ33587317-1BE8E435-3F0E-4BAF-8704-17044851BC6BQ33769283-CFBAD6E6-773F-422E-80CE-E08B00687375Q34634294-1BA66056-7C06-4FB7-A3AC-2343EB0AC4A0Q35077801-5BB4DE19-708F-4A7F-95D3-94E08C7B5A75Q35942681-5D8FFD59-A4C5-4DC8-A941-3881ABCE2CDEQ36470890-A5BF4BD1-0A52-402B-A4F3-B99FEFAB965FQ36926701-04688D7E-831D-4B51-8012-F634BD0D4503Q36949588-1A60BDC1-1850-46D0-ABC4-67139890464AQ37967732-86EE3FB9-CD8B-4E7A-8F7F-9FDE9E18B803Q40653669-B209DBE5-9FAD-4239-A90F-97EE077E69FDQ41645414-A210F18B-4B69-4FD4-B681-7F0E96D6812EQ52574472-FFB584B3-BF14-449F-BA81-FBF1D1DDF844
P2860
Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Chemokine receptors and co-sti ...... unodeficiency virus infection.
@ast
Chemokine receptors and co-sti ...... unodeficiency virus infection.
@en
type
label
Chemokine receptors and co-sti ...... unodeficiency virus infection.
@ast
Chemokine receptors and co-sti ...... unodeficiency virus infection.
@en
prefLabel
Chemokine receptors and co-sti ...... unodeficiency virus infection.
@ast
Chemokine receptors and co-sti ...... unodeficiency virus infection.
@en
P2860
P1476
Chemokine receptors and co-sti ...... unodeficiency virus infection.
@en
P2093
Brian J Willett
P2860
P356
10.1016/J.VETIMM.2008.01.012
P577
2008-01-19T00:00:00Z